Published in Br J Cancer on March 01, 1995
Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92
E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res (2003) 2.61
Tumour markers of prognosis in colorectal cancer. Br J Cancer (1999) 1.68
Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol (1998) 1.49
Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res (2005) 1.27
Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer (1999) 1.26
Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci U S A (1999) 1.23
Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg (2000) 1.08
Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut (1997) 1.01
Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol (1996) 1.00
Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis (2012) 0.97
Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig Dis Sci (2013) 0.96
Prognostic significance of E-cadherin expression in human colorectal cancer tissue. Surg Today (1997) 0.95
Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer (2003) 0.94
E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol (2008) 0.91
Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol (1998) 0.91
Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch (2006) 0.90
Interferon-β signaling contributes to Ras transformation. PLoS One (2011) 0.89
Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. J Clin Pathol (1997) 0.88
Tumour-suppressive function of SIRT4 in human colorectal cancer. Br J Cancer (2015) 0.85
Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy. Radiat Oncol (2012) 0.84
Effects of carbon dioxide and nitrogen on adhesive growth and expressions of E-cadherin and VEGF of human colon cancer cell CCL-228. World J Gastroenterol (2003) 0.83
cDNA array analysis for prediction of hepatic metastasis of colorectal carcinoma. Surg Today (2006) 0.80
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression. Virchows Arch (2005) 0.79
Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer. Surg Today (1999) 0.77
Reduced expression of E-cadherin in human non-small cell lung carcinoma. Cancer Res Treat (2004) 0.76
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem (1990) 6.13
Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol (1993) 5.22
Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol (1983) 4.01
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol (1993) 2.84
E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res (1993) 2.55
Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res (1993) 2.09
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89
Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol (1993) 1.83
The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study. Development (1988) 1.64
Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer (1993) 1.36
Prognostic factors in colorectal cancer. Br J Surg (1992) 1.25
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer (1993) 1.23
The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br J Cancer (1993) 1.09
Colorectal carcinoma: importance of clinical and pathological factors in survival. Ann R Coll Surg Engl (1994) 0.87
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Biological diversity in metastatic neoplasms: origins and implications. Science (1982) 3.95
A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer (1987) 3.80
Simulation technology for health care professional skills training and assessment. JAMA (1999) 3.49
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
The biology of cancer invasion and metastasis. Adv Cancer Res (1978) 2.94
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76
Early onset of breast cancer in a group of British black women. Br J Cancer (2008) 2.47
The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol (1979) 2.42
In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res (1980) 2.40
Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol (2004) 2.36
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet (1983) 2.30
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res (1984) 2.13
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest (1999) 2.10
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst (1984) 2.08
Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology (1995) 2.02
BEME Guide No. 1: Best Evidence Medical Education. Med Teach (1999) 2.01
Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology (1993) 1.97
Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res (1980) 1.97
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol (1993) 1.78
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer (2001) 1.64
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut (2010) 1.63
Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol (2005) 1.61
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol (1992) 1.61
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut (2000) 1.59
Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics (1995) 1.59
Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res (1995) 1.56
The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol (1993) 1.56
Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology (1993) 1.55
Multiple tissue core arrays in histopathology research: a validation study. J Pathol (2000) 1.51
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res (1990) 1.51
Mammary hamartoma--a review of 35 cases. Histopathology (1992) 1.50
Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res (1993) 1.50
hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A (1993) 1.48
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol (1998) 1.41
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet (1992) 1.41
Trefoil peptides. Gut (1999) 1.41
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res (1995) 1.40
An international virtual medical school (IVIMEDS): the future for medical education? Med Teach (2002) 1.38
Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizer. Br J Cancer (1986) 1.36
Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol (2008) 1.35
Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J Virol (1997) 1.34
Molecular characteristics of serrated adenomas of the colorectum. Gut (2002) 1.31
X-ray scatter signatures for normal and neoplastic breast tissues. Phys Med Biol (1999) 1.30
Colocalization of kindlin-1, kindlin-2, and migfilin at keratinocyte focal adhesion and relevance to the pathophysiology of Kindler syndrome. J Invest Dermatol (2008) 1.29
Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A (1996) 1.29
Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res (1994) 1.27
Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology (1999) 1.26
'Seed and soil' revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev (1982) 1.25
Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Cancer Res (1990) 1.24
AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer (2001) 1.24
Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract (1992) 1.24
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer (2009) 1.24
An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology (1999) 1.23
The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol (1994) 1.23
Mechanisms of tumour metastasis. Eur J Cancer (1998) 1.22
HER2 testing in the UK: further update to recommendations. J Clin Pathol (2008) 1.22
Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol (1997) 1.22
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol (1998) 1.20
Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer (1999) 1.19
Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest (1998) 1.19
Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol (2004) 1.18
Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol (2001) 1.18
Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp (1998) 1.18
The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'. J Pathol (1993) 1.17
Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen (2000) 1.16
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer (2002) 1.16
Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol (2001) 1.16
Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res (1991) 1.16
Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. Br J Cancer (1998) 1.16
A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol (2008) 1.15
Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. Cancer Res (1988) 1.15
Update on hepatic stem cells. Liver (2001) 1.15
Bile duct blood supply. Its importance in human liver transplantation. Transplantation (1978) 1.14
The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain OF CD36. J Biol Chem (2000) 1.14
Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst (1985) 1.14
Use of charge coupled device camera for imaging of intracellular phthalocyanines. Photochem Photobiol (1989) 1.13
Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J Cell Sci (1995) 1.13
Experiences of patients with false positive results from colorectal cancer screening. Br J Gen Pract (1990) 1.13
Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol (2006) 1.12
Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol (2001) 1.12
Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut (2008) 1.12
Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Res (2000) 1.11
The new stem cell biology: something for everyone. Mol Pathol (2003) 1.10
Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res (1981) 1.10
MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol (1998) 1.09